Arkolith/Insider Trading/CRGX/Form 4

Chapman Gina

President & CEO, DirectorCARGO Therapeutics, Inc. (CRGX) · full profile →Form 4 · filed Sep 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$254K
Net Open-Market Flow
-$254K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2024Option exercise(M)3K$5.03$15K107K
Sep 19, 2024Sell(S)3K$25.03$74K104K
Sep 18, 2024Sell(S)7K$25.09$180K104K
Sep 18, 2024Option exercise(M)7K$5.03$36K111K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2024Option exercise(M)3K—$0550K
Sep 18, 2024Option exercise(M)7K—$0552K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000492) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML